An official website of the United States government.

We've made some changes to If the information you are looking for is not here, you may be able to find it on the EPA Web Archive or the January 19, 2017 Web Snapshot.

EPA Research

FutureTox IV Progress to Maturity: Predictive Toxicology for Healthy Children

Date and Time

Wednesday 11/14/2018 1:00PM EST to Friday 11/16/2018 4:30PM EST
Add to Calendar


FUTURETOX IV is put on by the Society of Toxicology. The meeting is focused on bringing together scientists to bridge the translation from historical approaches to Tox21 implementation relative to risk assessment and regulatory decision-making for matters pertaining to developmental health, lifestage progression, and the human reproductive cycle. The meeting also will look at implementing the 21st-century vision and regulatory considerations relevant to commercial chemicals in the environment and medical products for guidance based on new results. Get the full details: FutureTox IV Progress to Maturity: Predictive Toxicology for Healthy Children Exit

EPA Presentations
Date Time  Session Details Role/Scientist
11/14 1PM-1:30PM Greeting and Conference Charge Chair: Thomas B. Knudsen, PhD
11/15 9AM-12PM PLENARY SESSION II: In Vitro Data and In Silico Models for Children's Health Research Co-Chair: Barbara Wetmore, PhD
11/15 10:30AM-11AM PLENARY SESSION II Topic: Merging In Vitro and In Silico Approaches for Translational Life Stage Assessments Presenter: Barbara Wetmore, PhD
11/15 11AM-11:30AM PLENARY SESSION II Topic: In Silico Dynamic Models for Developmental Toxicity Presenter: Thomas B. Knudsen, PhD
11/16  7AM-10AM Dine and Dash[board] Breakfast Co-Chair: Monica Linnenbrink
11/16 11AM-11:30AM PLENARY SESSION IV Topic: Amended Toxic Substances Control Act and Children's Health Risk Assessment Presenter: Brenda Foos, MEM
11/16 1PM-3PM Breakout Group: Novel In Vitro and In Silico Strategies for Assessing Developmental Health Effects Discussion Leader: Jill Franzosa
11/16 1PM-3PM Breakout Group: Novel Strategies for Early Lifestage Toxicokinetic and Exposure Assessment Discussion Leader: Barbara Wetmore, PhD
11/16 1PM-3PM

Breakout Group: Regulatory Gaps and Consideration of Uncertainty and Variability for Developmental Risk Assessment and Decision-Making

Discussion Leader: Sue Euling, PhD
11/16 4PM-4:30PM Wrap up and next steps  Chair: Thomas B. Knudsen, PhD